Literature DB >> 30180757

New 2017 ACC/AHA hypertension guideline: Implications for a Latin American country like Peru.

Akram Hernández-Vásquez1, Marilina Santero2.   

Abstract

Entities:  

Year:  2018        PMID： 30180757     DOI： 10.1177/2047487318799489

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  6 in total

Review 1.  Prevalence of high blood pressure under 2017 ACC/AHA guidelines: a systematic review and meta-analysis.

Authors:  Peisheng Xiong; Zhixi Liu; Meijuan Xiong; Feng Xie
Journal:  J Hum Hypertens       Date:  2020-12-08       Impact factor: 3.012

2.  Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS).

Authors:  Mohammad Saatchi; Mohammad Ali Mansournia; Davood Khalili; Rajabali Daroudi; Kamran Yazdani
Journal:  Risk Manag Healthc Policy       Date:  2020-08-05

3.  Diseases and access to treatment by the Peruvian prison population: an analysis according to gender.

Authors:  A Hernández-Vásquez; C Rojas-Roque
Journal:  Rev Esp Sanid Penit       Date:  2020-04-27

4.  Prevalence and Predictors of High Blood Pressure Among Women of Reproductive Age and Children Aged 10 to 14 Years in Guatemala.

Authors:  Cassandra M Pickens; Rafael Flores-Ayala; O Yaw Addo; Ralph D Whitehead; Mireya Palmieri; Manuel Ramirez-Zea; Yuling Hong; Maria Elena Jefferds
Journal:  Prev Chronic Dis       Date:  2020-07-23       Impact factor: 2.830

5.  Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012-2015.

Authors:  Samaneh Asgari; Pegah Khaloo; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

6.  Socioeconomic determinants of hypertension and prehypertension in Peru: Evidence from the Peruvian Demographic and Health Survey.

Authors:  Diego Chambergo-Michilot; Alexis Rebatta-Acuña; Carolina J Delgado-Flores; Carlos J Toro-Huamanchumo
Journal:  PLoS One       Date:  2021-01-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.